BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17715262)

  • 1. Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1.
    Weimbs T
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1423-32. PubMed ID: 17715262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease.
    Low SH; Vasanth S; Larson CH; Mukherjee S; Sharma N; Kinter MT; Kane ME; Obara T; Weimbs T
    Dev Cell; 2006 Jan; 10(1):57-69. PubMed ID: 16399078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?
    Weimbs T
    Cell Cycle; 2006 Nov; 5(21):2425-9. PubMed ID: 17102641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.
    Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
    Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling.
    Xu C; Rossetti S; Jiang L; Harris PC; Brown-Glaberman U; Wandinger-Ness A; Bacallao R; Alper SL
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F930-45. PubMed ID: 17090781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystin-1 regulates STAT activity by a dual mechanism.
    Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Polycystin-1 Function by Calmodulin Binding.
    Doerr N; Wang Y; Kipp KR; Liu G; Benza JJ; Pletnev V; Pavlov TS; Staruschenko A; Mohieldin AM; Takahashi M; Nauli SM; Weimbs T
    PLoS One; 2016; 11(8):e0161525. PubMed ID: 27560828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystin-1, the product of the polycystic kidney disease gene PKD1, is post-translationally modified by palmitoylation.
    Roy K; Marin EP
    Mol Biol Rep; 2018 Oct; 45(5):1515-1521. PubMed ID: 30073588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
    Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular advances in autosomal dominant polycystic kidney disease.
    Gallagher AR; Germino GG; Somlo S
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tale of two tails: ciliary mechanotransduction in ADPKD.
    Cantiello HF
    Trends Mol Med; 2003 Jun; 9(6):234-6. PubMed ID: 12829010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.
    Shillingford JM; Murcia NS; Larson CH; Low SH; Hedgepeth R; Brown N; Flask CA; Novick AC; Goldfarb DA; Kramer-Zucker A; Walz G; Piontek KB; Germino GG; Weimbs T
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5466-71. PubMed ID: 16567633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of autosomal dominant polycystic kidney disease.
    Al-Bhalal L; Akhtar M
    Adv Anat Pathol; 2005 May; 12(3):126-33. PubMed ID: 15900113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
    Nauli SM; Rossetti S; Kolb RJ; Alenghat FJ; Consugar MB; Harris PC; Ingber DE; Loghman-Adham M; Zhou J
    J Am Soc Nephrol; 2006 Apr; 17(4):1015-25. PubMed ID: 16565258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug therapy for polycystic kidney disease: a review and perspective.
    Aguiari G; Catizone L; Del Senno L
    Am J Nephrol; 2013; 37(2):175-82. PubMed ID: 23428809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.